ASK1-IN-12
ASK1-IN-12 is an ASK1 inhibitor with an IC50 of 6.3 nM. ASK1-IN-12 inhibits TNF-α-induced activation of the ASK1-p38/JNK pathway. ASK1-IN-12 can reduce free fatty acid-induced cholesterol increase, lipid droplet accumulation and improves hepatocellular steatosis. ASK1-IN-12 can be used for the research of non-alcoholic steatohepatitis (NASH).
For research use only. We do not sell to patients.
- Formula: C24H22F3N9O
- Molecular Weight:509.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
ASK1-IN-12 (Compound 20) (1-6 μM; 24 h) reduces total cholesterol, triglyceride, low-density lipoprotein cholesterol and lipid droplet accumulation and improves hepatocellular steatosis in free fatty acid-induced LO2 cells[1].
ASK1-IN-12 (1-1000 nM; 24 h) inhibits TNF-α-induced activation of the ASK1-p38/JNK pathway in HepG2 cells[1].
ASK1-IN-12 (0.5-5 μM; 24 h) exhibits no significant cytotoxicity to LO2 hepatocytes, with cell viability maintained above 80%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HepG2 cells
-
Concentration:1, 10, 100 and 1000 nM
-
Incubation Time:24 h
-
Result:Reducd the phosphorylation ratios of p-ASK1/ASK1, p-JNK/JNK, and p-p38/p38.
Chemical Information
-
Molecular Weight 509.49
-
Formula C24H22F3N9O
-
SMILES
O=C(NC1=CC=CC(C2=NN=CN2[C@H](C(F)(F)F)C)=N1)C3=NN4C=CC(C5=CN(C(C)C)N=C5)=CC4=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Liver Histomorphometry
Liver histomorphometry is a quantitative histological approach used to measure structural alterations in hepatic tissue, including parenchymal loss, steatosis, fibrosis, and vascular remodeling, by combining stained tissue section analysis with stereological or computerized image-based measurements. Classical morphometric frameworks quantify volume fractions of liver compartments and fibrotic regions using systematic sampling and image analysis, enabling objective comparison of pathological changes across experimental groups. These approaches are widely applied in liver cirrhosis and fibrosis studies to reduce subjectivity in histological scoring and improve reproducibility of tissue evaluation. Recent methodological advances integrate automated image analysis and radiomics-based extraction of histological features from standard liver stains (e. g. , H&E and fibrotic stains), enabling quantitative correlation between morphometric features and fibrosis stages in non-alcoholic fatty live
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)